Catalyst Wire Dossier Catalyst Wire Dossier

Tetravalent dengue virus vaccine (investigational)

· National Institute of Allergy and Infectious Diseases (NIAID)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tetravalent dengue virus vaccine (investigational), covering 2013-01-03 to 2013-01-03. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Safety and Immune Response of Five Admixtures of a Tetravalent Dengue Virus Vaccine [Phase 1]

See pricing